Use of proton pump inhibitors are associated with higher mortality in hospitalized patients with COVID-19

BACKGROUND: The adverse effects of proton pump inhibitors (PPIs) on pneumonia have been well reported. However, the relationship between the use of PPIs and the adverse outcomes of coronavirus disease 2019 (COVID-19) is currently inconclusive. In this study, we aimed to explore the relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shengyong, Jin, Zhichao, Peng, Chi, Li, Dongdong, Cheng, Yi, Zhu, Ronghui, He, Jia, Wu, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Global Health 2022
Materias:
Research Theme 1: COVID-19 Pandemic
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849264/
https://www.ncbi.nlm.nih.gov/pubmed/35198150
http://dx.doi.org/10.7189/jogh.12.05005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8849264/
https://www.ncbi.nlm.nih.gov/pubmed/35198150
http://dx.doi.org/10.7189/jogh.12.05005

Ejemplares similares